What people say

" The biotech sector is going through an exciting phase as a maturing industry seeks to flourish in a new financial landscape. Now, more than ever, biotech businesses need the skill, determination and experience that I have seen in the team at 4D. "

Translational Medicine Consulting Service

Professor Martin Wehling has a long and distinguished career in academia and industry, and has developed particular expertise in assessment of translational medicine projects.  These assessments achieve two goals: a quantification of the probabilities of success or failure for particular projects, and identification of specific weaknesses, the mitigation of which will improve the likelihood of success.

What this can provide

In combination with the expertise and networks of 4D Biomedical and Apex consulting, we are able to offer a complete consulting service for biomedical and drug companies, funding agencies, regulatory authorities, venture capital and academia to:
- detect promising projects with high potential for exploitation
- rate funding applications in regard to their translational potential and prioritize them
- balance risk in a portfolio
- define and implement a strategy for the development of translational aspects in given projects’

Professor Martin Wehling

As director of discovery medicine at AstraZeneca from 2004-2006 he developed deep insight into translational processes and assessment. Returning to academia in 2007, he is at the forefront of the understanding and practice of translational medicine. Assessment of translational medicine projects is a major challenge and opportunity, for which Dr Wehling has unparalleled expertise (see bibliography below).

Bibliography:

Wehling M. Translational medicine: can it really facilitate the transition of research "from bench to bedside"? Eur J Clin Pharmacol 62, 91-95, 2006
Wehling M. Translational science in medicine - implications for the pharmaceutical industry. Int J Pharm Med 20, 303-310, 2006
Wehling, M. Translational medicine: science or wishful thinking? J Transl Med 6, 31, 2008
Wehling M. Translatability assessment of drug projects: what needs to be scored to predict success? Nature Rev Drug Discov 8, 541-546, 2009
Wehling M., ed. Principles of translational science in medicine: from bench to bedside. Textbook, Cambridge University Press, to appear in January 2010’